Literature DB >> 23093124

Primary bone tumours of the talus: the Scottish Bone Tumour Registry experience.

S W Bell1, P S Young, A Mahendra.   

Abstract

BACKGROUND: Primary bone tumours of the talus are rare and the existing literature is limited. The aim of this study was to investigate the epidemiology of primary bone tumours affecting this uncommon site and suggest a management protocol for these tumours.
METHODS: We retrospectively reviewed the Scottish Bone Tumour Register from January 1954 to May 2010 and included all primary bone tumours of the talus.
RESULTS: We identified only twenty three bone tumours over fifty six years highlighting the rarity of these tumours. There were twenty benign and three malignant tumours with a mean age of twenty eight years. A delay in presentation was common with a mean time from onset of symptoms to diagnosis of ten months.
CONCLUSIONS: Tumour types identified were consistent with previous literature. We identified cases of desmoplastic fibroma and intraosseous lipodystrophy described for the first time. We suggest an investigatory and treatment protocol for patients with a suspected primary bone tumour of the talus.
Copyright © 2012 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23093124     DOI: 10.1016/j.fas.2012.04.007

Source DB:  PubMed          Journal:  Foot Ankle Surg        ISSN: 1268-7731            Impact factor:   2.705


  3 in total

1.  Tumours of the talus - A pictorial review.

Authors:  Boo Sl; Saad A; Murphy J; Botchu R
Journal:  J Clin Orthop Trauma       Date:  2020-04-11

2.  Bone Tumours of the Talus: 18-Year Cohort of Patients With Rare Osteoid Lesions.

Authors:  Luke F Western; Rohit Dhawan; Gillian Cribb; Karen Shepherd; Paul Cool
Journal:  Cureus       Date:  2021-02-26

3.  Management and retrospective analysis of tumors and tumor-like lesions localized in the talus.

Authors:  Yaman Karakoç; Coşkun Ulucaköy
Journal:  Jt Dis Relat Surg       Date:  2021-01-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.